New hope drug tested for Tough-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing a new drug called AMT-253 for people with advanced melanoma or other solid tumors that have spread and cannot be removed by surgery. The study aims to find a safe dose and see if the drug can shrink tumors in patients who have already tried stand…
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC